SEC Form 4 · accession 0001128732-17-000031
Sunshine Biopharma Inc. · SBFM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steve N. Slilaty
Officer — Chief Executive Officer · Director
Period of report
Jul 20, 2017
Accepted (ET)
Sep 8, 2017 · 9:28 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001402328
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 20, 2017 | A | 14,000,000 | $0.001 | A | 52,384,373 | D |
Table II — derivative securities
No Table II lines on this filing.